Contract manufacturing & logistics

Genetically modified corn could soon make drugs

GM corn could soon be used to make drugs

By Natalie Morrison

Genetically modified corn could soon be used to mass-produce the enzymes used in rare-disease therapies, according to new research.

Pfizer signs Chinese CMO JV in China

Pfizer inks generics CMO JV with Hisun

By Gareth Macdonald

Pfizer and manufacturing partner Zhejiang Hisun Pharmaceuticals will set up a dedicated research centre to develop drugs for the Chinese market.

FDA warning for DPT Labs

update

FDA criticizes DPT's efforts to fix sterility problems

By Gareth Macdonald

US CDMO DPT Labs has not done enough to investigate sterility failures observed during a March inspection according to the Food and Drug Administration (FDA) which wants a ‘comprehensive evaluation’ of sterile drug operations.

GE rolls out 'off the shelf' MAb factories

GE launches range of 'off the shelf' MAb facilities

By Gareth Macdonald

GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.

Bosch Packaging launches new capsule filling tech

Bosch launches"future-proof" filling tech

By Natalie Morrison

Bosch packaging has launched two new capsule filling machines which it says are capable of handling all current and future applications.

some green, yesterday

update

Pfizer favours green contractors

By Gareth Macdonald

Pfizer wants the CROs, CMOs and other suppliers it works with to be green and says such firms have an advantage when it comes to winning contracts.

Aurobindo sets eyes on pharmaceutical API CRAMS biz

Aurobindo sets eyes on API CRAMS biz

By Natalie Morrison

Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.

Follow us

Products

View more

Webinars